Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer.

Bartl, Thomas; Grimm, Christoph; Mader, Robert M; Zielinski, Christoph; Prager, Gerald; Unseld, Matthias; Herac-Kornauth, Merima

Bartl, Thomas; Grimm, Christoph; Mader, Robert M; Zielinski, Christoph; Prager, Gerald; Unseld, Matthias; Herac-Kornauth, Merima.

Afiliación

Bartl T; Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Medical University of Vienna, 1090 Wien, Austria.
Grimm C; Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Medical University of Vienna, 1090 Wien, Austria.
Mader RM; Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Wien, Austria.
Zielinski C; Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Wien, Austria.
Prager G; Department of Medicine I, Division of Oncology, Medical University of Vienna, 1090 Wien, Austria.
Unseld M; Academy for Ageing Research, Haus der Barmherzigkeit, 1160 Wien, Austria.
Herac-Kornauth M; Department of Pathology, Medical University of Vienna, 1090 Wien, Austria.

J Pers Med ; 13(8)2023 Jul 26.

Article en En | MEDLINE | ID: mdl-37623437

Palabras clave

cervical cancer; mammalian target of rapamycin; palliative treatment; precision medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Pers Med Año: 2023 Tipo del documento: Article País de afiliación: Austria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google